Data / Drug companies / Takeda GmbH
Takeda GmbH: 24 products in the FDA NDC directory, labeler code 47234
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Takeda GmbH (labeler code 47234) lists 24 products in the FDA National Drug Code Directory. By type: 24 drugs for further processing. Its main marketing category is drugs for further processing. The newest product started marketing on May 18, 2018.
The request: Watch Takeda GmbH (FDA labeler code 47234): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 47234
- Products in commercial distribution
- 24
- Packages
- 24
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- May 1, 2000
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 24 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 24 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 13 | 54.2% |
| Tablet | 5 | 20.8% |
| Tablet, delayed release | 2 | 8.3% |
| Capsule, delayed release | 2 | 8.3% |
| Tablet, coated | 1 | 4.2% |
| Injection, powder, for solution | 1 | 4.2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Dexlansoprazole | 47234-1148 | Capsule, delayed release | Drugs for further processing | May 18, 2018 |
| Dexlansoprazole | 47234-1147 | Capsule, delayed release | Drugs for further processing | May 18, 2018 |
| Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate | 47234-2501 | Tablet | Drugs for further processing | February 7, 2018 |
| Roflumilast | 47234-0088 | Tablet | Drugs for further processing | January 29, 2018 |
| Emtricitabine and tenofovir alafenamide fumarate | 47234-2002 | Tablet, film coated | Drugs for further processing | April 4, 2016 |
| Vortioxetine | 47234-4120 | Tablet, film coated | Drugs for further processing | October 2, 2013 |
| Vortioxetine | 47234-4110 | Tablet, film coated | Drugs for further processing | October 2, 2013 |
| Vortioxetine | 47234-4105 | Tablet, film coated | Drugs for further processing | October 2, 2013 |
| Pantoprazole sodium | 47234-0923 | Injection, powder, for solution | Drugs for further processing | August 12, 2013 |
| Alogliptin and metformin hydrochloride | 47234-1255 | Tablet, film coated | Drugs for further processing | February 5, 2013 |
| Alogliptin and metformin hydrochloride | 47234-1251 | Tablet, film coated | Drugs for further processing | February 5, 2013 |
| Alogliptin benzoate and pioglitazone hydrochloride | 47234-7106 | Tablet, film coated | Drugs for further processing | February 7, 2012 |
| Alogliptin benzoate and pioglitazone hydrochloride | 47234-7105 | Tablet, film coated | Drugs for further processing | February 7, 2012 |
| Alogliptin benzoate and pioglitazone hydrochloride | 47234-7104 | Tablet, film coated | Drugs for further processing | February 7, 2012 |
| Alogliptin benzoate and pioglitazone hydrochloride | 47234-7102 | Tablet, film coated | Drugs for further processing | February 7, 2012 |
| Roflumilast | 47234-0095 | Tablet | Drugs for further processing | February 28, 2011 |
| Colchicine | 47234-0119 | Tablet, film coated | Drugs for further processing | September 1, 2009 |
| Pioglitazone and glimepiride | 47234-3043 | Tablet | Drugs for further processing | July 28, 2006 |
| Pioglitazone and glimepiride | 47234-3023 | Tablet | Drugs for further processing | July 28, 2006 |
| Efavirenz, emtricitabine, and tenofovir disoproxil fumarate | 47234-0101 | Tablet, film coated | Drugs for further processing | July 20, 2006 |
| Emtricitabine and tenofovir disoproxil fumarate | 47234-0701 | Tablet, film coated | Drugs for further processing | August 2, 2004 |
| Tenofovir disoproxil fumarate | 47234-0401 | Tablet, coated | Drugs for further processing | October 26, 2001 |
| Pantoprazole sodium | 47234-0843 | Tablet, delayed release | Drugs for further processing | May 1, 2000 |
| Pantoprazole sodium | 47234-0841 | Tablet, delayed release | Drugs for further processing | May 1, 2000 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.